GLP-1 Medications List: Names, Forms and Label Uses

Short answer: As of November 1, 2026, DailyMed carries current US labels for GLP-1 medicines with these active ingredients: semaglutide (Ozempic®, Rybelsus®, Wegovy®), liraglutide (Victoza®, Saxenda® and generics), dulaglutide (Trulicity®), tirzepatide (Mounjaro®, Zepbound®), orforglipron (Foundayo®) and exenatide, plus two pens that pair a long-acting insulin with lixisenatide or liraglutide. They come as weekly shots, daily shots or daily tablets. Each label lists specific uses, mainly type 2 diabetes or weight management, and your prescriber decides which, if any, fits you.

What counts as a GLP-1 medicine?

A GLP-1 medicine acts on the receptor for glucagon-like peptide-1, a hormone the body makes. The labels call these medicines GLP-1 receptor agonists: the Foundayo label, for example, says its medicine “binds to and activates the human GLP-1 receptor.” Tirzepatide (Mounjaro, Zepbound) is usually grouped with them, but its label says it acts on two receptors: “Tirzepatide is a GIP receptor and GLP-1 receptor agonist.” For how the class works, see What is a GLP-1?.

Which GLP-1 medicines have current US labels?

The table lists each product with its label on DailyMed, checked on November 1, 2026. Uses are shortened from Section 1 of each label; strengths and dosing are left to your prescriber.

Medicine	Active ingredient	How it is taken	Uses listed in Section 1	Label date
Ozempic injection	Semaglutide	Shot under the skin, once weekly	Blood sugar control in adults with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes and heart disease; lowering the risk of kidney decline, kidney failure and heart death in adults with type 2 diabetes and chronic kidney disease	June 1, 2026
Ozempic tablets and Rybelsus	Semaglutide	Tablet, once daily, on an empty stomach	Blood sugar control in adults with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes at high risk	January 30, 2026
Wegovy injection	Semaglutide	Shot under the skin, once weekly	Lowering the risk of major heart events in adults with heart disease and obesity or overweight; weight reduction in adults and in children 12 and older with obesity; a liver condition (MASH) with moderate to advanced fibrosis in adults	June 18, 2026
Wegovy tablets	Semaglutide	Tablet, once daily, on an empty stomach	Lowering the risk of major heart events in adults with heart disease and obesity or overweight; weight reduction in adults	June 18, 2026
Victoza	Liraglutide	Shot under the skin, once daily	Blood sugar control in adults and children 10 and older with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes and heart disease	October 14, 2025
Saxenda	Liraglutide	Shot under the skin, once daily	Weight reduction in adults, and in children 12 and older who weigh more than 132 lbs (60 kg) and have obesity	February 25, 2026
Trulicity	Dulaglutide	Shot under the skin, once weekly	Blood sugar control in adults and children 10 and older with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes and heart disease or several heart risk factors	June 16, 2026
Mounjaro	Tirzepatide	Shot under the skin, once weekly	Blood sugar control in adults and children 10 and older with type 2 diabetes; lowering the risk of major heart events in adults with type 2 diabetes at high risk	August 27, 2026
Zepbound	Tirzepatide	Shot under the skin, once weekly	Weight reduction in adults with obesity, or overweight and a weight-related condition; moderate to severe obstructive sleep apnea in adults with obesity	August 28, 2026
Foundayo	Orforglipron	Tablet, once daily, with or without food	Weight reduction in adults with obesity, or overweight and a weight-related condition	July 29, 2026
Exenatide injection (brand-name and generic versions)	Exenatide	Shot under the skin, twice daily, within the hour before the morning and evening meals	Blood sugar control in adults with type 2 diabetes	May 27, 2026 (generic)
Insulin glargine and lixisenatide (combination pen)	Lixisenatide with a long-acting insulin	Shot under the skin, once daily, within the hour before the first meal	Blood sugar control in adults with type 2 diabetes	March 18, 2026
Insulin degludec and liraglutide (combination pen)	Liraglutide with a long-acting insulin	Shot under the skin, once daily, at the same time each day	Blood sugar control in adults with type 2 diabetes	October 14, 2025

Wegovy injection’s liver indication is under accelerated approval, which its label says may depend on a confirmatory trial. A DailyMed search on November 1, 2026 returned no current label for once-weekly extended-release exenatide or for lixisenatide on its own; if you used one of those before, ask your pharmacist what is available now.

Which GLP-1 medicines are for type 2 diabetes, and which are for weight?

Three active ingredients are sold under two brand names each, one labeled mainly for type 2 diabetes and one for weight management:

Active ingredient	Type 2 diabetes label	Weight management label
Semaglutide	Ozempic (injection and tablets), Rybelsus	Wegovy (injection and tablets)
Liraglutide	Victoza	Saxenda
Tirzepatide	Mounjaro	Zepbound

Dulaglutide (Trulicity), exenatide and the two insulin combinations are labeled for type 2 diabetes only. Foundayo is labeled for weight reduction only. For how the paired brands differ, see Ozempic vs Wegovy, Mounjaro vs Zepbound.

Which GLP-1 medicines come as pills?

Three labels cover tablets:

• Wegovy tablets (semaglutide), once daily on an empty stomach with up to 4 ounces of plain water; see Wegovy pill: what the label says.
• Rybelsus and Ozempic tablets (semaglutide), one shared label with the same empty-stomach steps. Ozempic tablets are a newer tablet formulation, and the label says the two “are not substitutable on a mg-to-mg basis,” so any switch goes through your prescriber and pharmacist.
• Foundayo (orforglipron), once daily, with or without food; see Foundayo: what the label says.

For tablets next to the weekly shots, see GLP-1 pills vs shots.

Are there generic GLP-1 medicines?

Yes, for two ingredients. A DailyMed search on November 1, 2026 lists generic liraglutide injection from several manufacturers, with some labels matching the type 2 diabetes use and others the weight management use, and a generic exenatide injection. For semaglutide, tirzepatide and dulaglutide, the same search lists only the Novo Nordisk or Eli Lilly products and repackaged versions of them.

Compounded semaglutide or tirzepatide is not on this list. The FDA says it “does not review compounded drugs for safety, effectiveness or quality before they are marketed,” and advises getting a prescription from your doctor and filling it at a state-licensed pharmacy. Ask your prescriber and pharmacist about what you are taking.

Can you take two GLP-1 medicines together?

The labels advise against it. The Wegovy label says use with “other semaglutide-containing products or with any other GLP-1 receptor agonist is not recommended.” The Zepbound, Saxenda and Foundayo labels say the same about other GLP-1 receptor agonists, and the Victoza label says not to use it with other liraglutide products. The insulin combination pens contain a GLP-1 medicine too, so they count. Keep a full list of your medicines and show it to every prescriber and pharmacist.

What do the labels have in common?

The thirteen brand and generic labels behind the table all warn about inflammation of the pancreas (acute pancreatitis), severe stomach and bowel side effects, kidney problems from fluid loss, and the risk of food or liquid getting into the lungs during anesthesia or deep sedation. Most also open with a boxed warning about thyroid C-cell tumors seen in rodents. The twice-daily exenatide labels and the insulin glargine and lixisenatide label do not carry that boxed warning. For the side effect figures, see GLP-1 side effects, and for how long each medicine stays in the body, see how long GLP-1 medicines stay in your system.

How can you keep track?

If you switch between products, or move from a daily to a weekly medicine, the names and schedules can blur. Writing down which medicine, which form and which day helps at appointments. Weeko, a shot tracker coming to iPhone and Android, is being built around this kind of simple log. It is a logbook, not medical guidance.

When to call your doctor

Ask your prescriber which medicine on this list, if any, fits your situation, and before switching between products, forms or brands. Tell every prescriber and pharmacist about all your medicines, including insulin or a sulfonylurea, and about any planned surgery or procedure with anesthesia or deep sedation. The labels say to call right away for severe stomach pain that will not go away, with or without vomiting, and to get emergency help for signs of a serious allergic reaction. Tell your prescriber about a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. If you take too much of any medicine, call Poison Help at 1-800-222-1222.